• RT @aptar: A successful @CPhIWW Worldwide 2019 is behind us. #AptarPharma would like to thank everyone for coming to meet us! See you again…

Call us Today!
+1 (724) 443-1900

Case Studies of Foreign Particulate Analysis

Authors & ContributorsDavid Exline

January 23, 2019

Topics covered include analytical techniques and methods suitable for API particle sizing and in vitro bioequivalence for nasal drug products as well as preparation methods and a review of case studies. The presentation also provides FDA guidance related to particle size distribution (PSD) and regulatory considerations for PSD testing

View Webinar Here